Tag: neuroendocrine tumor

Neuroendocrine Cancer Survivor Featured on Discovery Fit & Health TV Show
THIS JUST IN: Tannis Brown, a pheochromocytoma patient and Vice President of the Pheo Para Troopers, will be featured on the Discovery Fit & Health Network on Monday, July 9 in a program titled Diagnosis: Dead or Alive.* The 60 minute show will focus…
READ MORE
Breaking News: FDA Approves Pfizer’s Sutent for Pancreatic NET Cancer Patients
The US Food and Drug Administration today announced approval of Pfizer’s Sutent (sunitinib) for advanced pancreatic neuroendocrine tumor cancer patients with tumors that cannot be removed by surgery or that have spread (metastasized) to …
READ MORE
Breaking News: FDA Approves Pfizer’s Sutent for Pancreatic NET Cancer Patients
The US Food and Drug Administration today announced approval of Pfizer’s Sutent (sunitinib) for advanced pancreatic neuroendocrine tumor cancer patients with tumors that cannot be removed by surgery or that have spread (metastasized) to …
READ MORE
1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT)
Since 1997, when he first used the radiolabeled peptide Y-90 DOTATOC (a somatostatin analogue) to treat a 15-year-old boy with a rare neuroendocrine tumor, called paraganglioma, and saw the boy go from being wheelchair-bound and in terrible pain to …
READ MOREClinical Trial Recruiting Neuroendocrine Tumor Patients with Pheochromocytoma or Paraganglioma
Neuroendocrine tumor patients with malignant pheochromocytoma or paraganglioma are being sought for a multi-center clinical trial conducted by Molecular Insight Pharmaceuticals, Inc. In the New York area, one of the clinical trial sites is the Mount…
READ MORE
Carcinoid Cancer Foundation Presents Symposium on Cutting-Edge Treatment
Determining Molecular Signature: A Guide for Targeted Therapy of Neuroendocrine Tumors
Imagine a treatment created just for you as a carcinoid or other neuroendocrine tumor patient based upon a personalized genomic analysis. This is the cutting-edge…
READ MOREWorldwide Neuroendocrine Tumor (NET) Cancer Awareness Day: November 10, 2010
An extraordinary, first of its kind event is planned for November 10, 2010: Worldwide NET (neuroendocrine tumor) Cancer Awareness Day. Leaders of carcinoid/NET patient support and advocacy groups from throughout the world have been brought together…
READ MORE
Carcinoid Cancer Foundation Thanks Silja Chouquet
During a recent meeting in Berlin of the international Steering Committee for Worldwide NET Cancer Awareness Day (WNCAD) on November 10, 2010, Grace Goldstein of the Carcinoid Cancer Foundation had the opportunity to hear a fascinating presentation…
READ MORE
More Information from “The Insurance Warrior” Now on Carcinoid Cancer Foundation Website
Insurance coverage for medical treatments and prescription drugs is a critical issue for carcinoid cancer and neuroendocrine tumor patients. The Carcinoid Cancer Foundation is delighted to partner with Laurie Todd, “The Insurance Warrior,” to …
READ MORE
Carcinoid Cancer Foundation Partners with “The Insurance Warrior”
Panic — it’s the feeling in the pit of your stomach upon learning that your insurance company has denied coverage for your medication or treatment. Laurie Todd, a survivor of late-stage appendix cancer, has gained a reputation as “The Insurance…
READ MORE